Low levels of stress hormone contributes to aging

When it comes to the stress hormone cortisol, balance is everything, according to a new study in Germany. 

There have been plenty of studies that have indicated that too much stress can play a key role in speeding up the aging process [1]. However, it turns out that having low quantities of the stress hormone cortisol in your body is not good for you either. So what is good stress?

Longevity.Technology: Commonly known as the stress hormone, or the “fight or flight” chemical, cortisol is what causes the body to prepare to react in the face of real or perceived danger. It’s the reason your heart rate speeds up, your blood vessels constrict and your muscles tense as you prepare to deal with impending trouble.

Having raised levels of cortisol in your bloodstream on an ongoing basis can lead to health problems because it can suppress the immune system. However, it’s all about balance. According to the latest research, low cortisol levels can cause issues of their own, resulting in inflammation and premature aging.

Pharmaceutical scientists Alexandra K. Kiemer and Jessica Hoppstädter from Saarland University, writing in the journal Aging Cell [2] have revealed that low levels of cortisol, together with a protein known as GILZ can trigger inflammatory responses in the body. 

As we age, the body’s specific immune system, which protected us from the pathogens we have come into contact with, deteriorates while the nonspecific immune system, which protects against a wider range of pathogens, can become overactive, leading to inflammation and resulting in conditions which are more prevalent in the elderly, such as arthritis; this, we know:

“This has been well-known for a long time,” said Professor Kiemer. “In fact, the scientific community refers to this phenomenon as ‘inflammaging’ – a portmanteau word that combines the two inseparably linked processes of inflammation and aging.”

What has been less clear, however, is the exact cause of these inflammatory responses. Now, the research from Professor Kiemer’s team, including lead researcher Dr. Hoppstädter has shed more light on the complex processes involved. 


 

“All of these projects are still very much in the realm of basic research. A huge amount of work needs to be done before we have a medically effective drug.”

 


 

Levels of cortisol are lower in the elderly. Plus, the ability of macrophages, which are an important type of immune cells capable of activating inactive cortisol, also declines with age. This decrease in macrophage function can lead to an increase in inflammation.  

The latest research from the Saarbrücken pharmaceutical research team has shown that there is one particular protein involved in macrophage malfunction in the elderly. The levels of this protein, Glucocorticoid-induced leucine zipper, or GILZ, are regulated in part by cortisol. 

Kiemer and her team have been examining GILZ for a number of years and have discovered that lower cortisol causes macrophages to produce less GILZ, which leads to an inflammatory response. The research team genetically deactivated the GILZ protein in their study, confirming their theory that macrophages were activated as a result, in-turn leading to an increase in chronic inflammation response. 


 

The German team is now involved in further research to find new active compounds which could increase GILZ levels in the human body in order to help to prevent this inflammatory process. 

 


 

Their continued research is part of a body of work examining how preventing inflammation could be key to stymieing premature aging. An Italian team has determined that lengthening and maintaining telomeres could combat inflamm-aging. Meanwhile, a Chinese study has indicated that growth differentiation factor 15 has a key role to play in regulating age-related inflammatory response

However, Professor Kiemer explained that any treatment as a result of her team’s research would not be simply looking at turning on or off the GILZ protein, which can have both beneficial and deleterious effects on the human body. She went on to point out: “All of these projects are still very much in the realm of basic research. A huge amount of work needs to be done before we have a medically effective drug.” 

While it may be a number of years before any treatment is developed as a result, their work certainly adds an interesting new element in the study of inflammatory response and how it could eventually be controlled to increase human Longevity.

It’ll take time, so please don’t get stressed-out about it: ok, well maybe a little stress might help.

[1] https://bit.ly/3adom37

[2] https://bit.ly/2PIIKji

Image by Gerd Altmann from Pixabay

Carla Heyworth
Carla is sub editor at Longevity.Technology and she's the glue that keeps the team on track and the articles rolling-out. She has an extensive background in B2B communications, events and marketing. Carla's a visual person and can often be found behind a camera or editing photos

Latest articles

AI app reveals your biological age – and how to slow it down

Only as old as you feel ... or only as old as your Young.AI app tells you? We use our phones for just about everything...

Psychobiome: trusting your gut for Longevity

Scientists studying how the microbiome affects our mood aim to develop gut microbiome-modulating formulations to treat depression and other brain diseases. Recent work from Katya...

Startup Showcase: Jinfiniti: What do you think?

Comprehensive biomarker tech: Invest, buy, or both? It's time to have your say on Jinfiniti. We like what Jinfiniti are doing; but that's just our...

When AI means artificial immortality: just ask Alexa

Hereafter is turning dead ends into conversational opportunities. Understandably, we use Longevity in a mostly physical sense - extending lifespan and healthspan and combating aging...